Private equity market AUM set to more than double, while secondaries (13.1%) predicted to see strongest annualized growth in forecast period of 2023 to 2029 LONDON, Sept. 18, 2024 (Korea Bizwire) – Preqin, the global leader in alternative assets data, tools, and insights, today published its Future of Alternatives 2029 report. Preqin forecasts the global alternatives industry to [...]
Presentations to highlight progress in development of IND candidates ZW220 and ZW251 based on Zymeworks’ proprietary antibody-drug conjugate development platforms VANCOUVER, British Columbia, Sept. 18, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME) a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat cancers and [...]
Join executives from ExxonMobil Low Carbon Solutions, Dow, Talos and Chevron New Energies as event covers the CCUS value chain through opportunities, risks and economic viability trends LONDON/HOUSTON/SINGAPORE, 17 September 2024 – Momentum for carbon capture, utilization and storage (CCUS) is growing as a buoyant project pipeline is attracting attention from leading companies, but CCUS deployment [...]
97% accuracy rate in detecting cotton fields, over 80% accuracy in determining organic status Stuttgart, Germany, Sept. 17, 2024 (Korea Bizwire) – In a pioneering move that could reshape sustainable agriculture, the Global Organic Textile Standard (GOTS) and AI firm Marple have unveiled the results of their revolutionary Satellite Cotton Monitoring Project in India, demonstrating [...]
Topline data from FIBRONEER™-IPF show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change from baseline in Forced Vital Capacity [mL] at week 52 versus placebo. The FIBRONEER™-IPF trial is the largest trial in idiopathic pulmonary fibrosis (IPF) conducted to date. Patients were recruited in over 330 sites and in [...]
WAKE FOREST, N.C. and ADELAIDE, Australia, Sept. 13, 2024 (Korea Bizwire) – Avance Clinical, the market-leading CRO for biotechs, announced today that Avance Clinical will represent the CRO sector at the Australian Clinical Trials Roadshow (September 17-20) to share the unparalleled time, cost and quality opportunities for early phase US biotechs. Register Here Key Avance Clinical Australia [...]
New ResMed-supported research presented at ERS 2024 projects future Chronic Obstructive Pulmonary Disease (COPD) burden in Western Europe, accounting for increased air pollution, tobacco smoking, and vaping, with Non-Invasive Ventilation (NIV) enhancing survival rates. 88.7 million new COPD hospitalizations projected across Western Europe between 2019 – 2050 Vaping projected to incur almost €30 billion additional [...]
AMSTERDAM, Sept. 10, 2024 (Korea Bizwire) – The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue of how some of the largest pharmaceutical companies are reaching patients worldwide, especially in low- and middle-income countries (LMICs). Ahead of the 2024 Access to Medicine Index, the Foundation examined the [...]
WATERFORD, Ireland, Sept. 10, 2024 (Korea Bizwire) – With cybercrime running rampant and data breaches on the rise, trusted online casinos globally are arming themselves with the latest military-grade encryption technologies to outsmart even the most sophisticated cyber thugs. Minimum Deposit Casinos (MDC) – a leading global casino resource portal – said data breaches were becoming [...]
Beamion LUNG-1, Phase Ib met its primary endpoint, demonstrating a meaningful objective response rate (ORR) of 66.7%, as assessed by blinded independent central review (BICR)1 Preliminary activity in patients with brain metastases were also observed, with an intracranial response of 33% and 74% disease control rate (DCR) Zongertinib was generally well tolerated, with mostly mild [...]